Atelerix, a biotech institution revolutionizing compartment preservation and biologic carrier pinch its pioneering hydrogel encapsulation technology, coming announced an statement pinch Rodon Global (“Rodon”), nan established freight institution focused connected objective tests and supplier find headquartered successful South Africa. The collaboration comes astatine a pivotal clip arsenic Rodon actively expands operations crossed nan United States, UK, South Africa, and Singapore. By integrating Atelerix’s unsocial cryo-free preservation products wrong Rodon’s move logistics offering, nan collaboration will importantly broaden entree to safe shipping and retention solutions for temperature-sensitive biomaterials, without freezing.
Through an first MoU, Rodon will statesman offering Atelerix’s portfolio of hypothermic preservation solutions to customers, providing caller options to heighten ratio crossed biomedical investigation and therapeutic improvement workflows. The mutually-beneficial collaboration grants Atelerix entree to a caller customer guidelines via a trusted manufacture partner, whilst enabling Rodon to standard its services done a unsocial exemplary that addresses accepted challenges successful cold-chain logistics. This statement follows nan assignment of MineBio arsenic Atelerix’s exclusive supplier successful China1, further extending nan Company’s world web of logistics partners to present a cryo-free, cost-efficient carrier solution worldwide.
Atelerix’s patented hydrogels straight reside cryologistic bottlenecks by stabilizing membrane integrity and preserving biologic usability of cells and different biologic substances during transport. Samples tin stay successful a ready-to-use authorities astatine ambient temperatures for up to 2 weeks, reducing discarded and power consumption, and simplifying shipping and handling protocols. Optimized for full blood, superior cells, plated compartment models, organoids, tissues, and viruses, nan exertion is applicable crossed life subject and healthcare. It is peculiarly valuable for compartment and gene therapy manufacturing, wherever it offers a elastic solution for preservation crossed nan afloat workflow.
The world request for inexpensive, businesslike solutions for retention and carrier of biologic substances is continually increasing, starring to an urgent unmet request for innovative solutions, which our knowledgeable squad of hogs tin provide. Working alongside Rodon and our web of world distributors, we are expanding our scope to see nan booming South African life subject sector, catapulting take of our unsocial technologies successful nan region, and beyond. We look guardant to joining Rodon astatine SACRA successful October to showcase nan tremendous imaginable of our collaboration.”
Alastair Carrington, CEO, Atelerix
Leonard Neil Lazarus, CEO, Rodon Global, added: “Atelerix’s innovative attack to compartment preservation will revolutionize biologic carrier worldwide, overcoming proviso concatenation challenges associated pinch somesthesia delicate materials, peculiarly successful nan supplier find and objective investigation sectors. This business represents a important milestone and differentiator for Rodon, allowing america to flooded these challenges and proceed to scale, supporting our life subject customers to create and manufacture caller therapeutics.”
English (US) ·
Indonesian (ID) ·